Search research articles
Contact Us
Filters
Showing results (81-90 of 121) with videos related to
Page
of 13
Sort By:
Surgical Neurology
|
September 1, 1996
Acute pathologic features with angiographic correlates of the nearly or completely occluded lesions of the cervical internal carotid artery
S Endo, Y Hirashima, M Kurimoto, et al.
Analytical Biochemistry
|
January 1, 1989
Continuous spectrophotometric assay of phospholipase A2 activity hydrolyzing plasmalogens using coupling enzymes
Y Hirashima, M S Jurkowitz-Alexander, A A Farooqui, et al.
Journal of Neurosurgery
|
February 24, 2001
Establishment and characterization of a novel malignant astrocytoma cell line derived from a tumor removed in a patient with neurofibromatosis type 1
M Kurimoto, Y Hirashima, T Ogiichi, et al.
Stroke
|
October 6, 2001
Right sylvian fissure subarachnoid hemorrhage has electrocardiographic consequences
Y Hirashima, S Takashima, N Matsumura, et al.
The Histochemical Journal
|
November 1, 1993
Immunofluorescent localization of platelet-activating factor (PAF) in the rat
Y Hirashima, R Kato, S Endo, et al.
International Journal of Cancer
|
June 22, 2000
Identification and characterization of a Kunitz-type protease inhibitor in ascites fluid from patients with ovarian carcinoma
H Kobayashi, Y Hirashima, G W Sun, et al.
Journal of Neurosurgery
|
September 2, 1999
Suboccipital meningocele presenting as a huge retropharyngeal mass in a patient with neurofibromatosis Type 1. Case report
M Kurimoto, Y Hirashima, N Hayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 1, 1993
[Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer]
Y Hirashima, T Shimura, Y Tanaka, et al.
No to Shinkei = Brain and Nerve
|
August 1, 1983
[Simplified microdetermination of cerebral phospholipase A1, A2 and lysophopholipase]
Y Hirashima, K Koshu, K Kamiyama, et al.
Cancer Chemotherapy and Pharmacology
|
June 26, 2009
Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy
Yosuke Horita, Y Yamada, Y Hirashima, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 121) with videos related to
Sort By:
Page
of 13
Surgical Neurology
|
September 1, 1996
Acute pathologic features with angiographic correlates of the nearly or completely occluded lesions of the cervical internal carotid artery
S Endo, Y Hirashima, M Kurimoto, et al.
Analytical Biochemistry
|
January 1, 1989
Continuous spectrophotometric assay of phospholipase A2 activity hydrolyzing plasmalogens using coupling enzymes
Y Hirashima, M S Jurkowitz-Alexander, A A Farooqui, et al.
Journal of Neurosurgery
|
February 24, 2001
Establishment and characterization of a novel malignant astrocytoma cell line derived from a tumor removed in a patient with neurofibromatosis type 1
M Kurimoto, Y Hirashima, T Ogiichi, et al.
Stroke
|
October 6, 2001
Right sylvian fissure subarachnoid hemorrhage has electrocardiographic consequences
Y Hirashima, S Takashima, N Matsumura, et al.
The Histochemical Journal
|
November 1, 1993
Immunofluorescent localization of platelet-activating factor (PAF) in the rat
Y Hirashima, R Kato, S Endo, et al.
International Journal of Cancer
|
June 22, 2000
Identification and characterization of a Kunitz-type protease inhibitor in ascites fluid from patients with ovarian carcinoma
H Kobayashi, Y Hirashima, G W Sun, et al.
Journal of Neurosurgery
|
September 2, 1999
Suboccipital meningocele presenting as a huge retropharyngeal mass in a patient with neurofibromatosis Type 1. Case report
M Kurimoto, Y Hirashima, N Hayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 1, 1993
[Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer]
Y Hirashima, T Shimura, Y Tanaka, et al.
No to Shinkei = Brain and Nerve
|
August 1, 1983
[Simplified microdetermination of cerebral phospholipase A1, A2 and lysophopholipase]
Y Hirashima, K Koshu, K Kamiyama, et al.
Cancer Chemotherapy and Pharmacology
|
June 26, 2009
Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy
Yosuke Horita, Y Yamada, Y Hirashima, et al.
Page
of 13